GSTP1 and non-small cell lung carcinoma: MiR-133b is found to be able to decrease cisplatin resistance, and its overexpression suppresses cell growth and invasion in cisplatin-resistant NSCLC via regulating glutathione-S-transferase P1 (GSTP1) [45].